Published in Immunology on January 01, 1991
Vitamin D in inflammatory diseases. Front Physiol (2014) 1.10
Protective effect of thioredoxin upon NO-mediated cell injury in THP1 monocytic human cells. Biochem J (2000) 0.89
Effect of retinoic acid and vitamin D on the expression of interleukin-1 beta, tumour necrosis factor-alpha and interleukin-6 in the human monocytic cell line U937. Immunology (1993) 0.88
Regulation of c-fgr messenger RNA levels in U937 cells treated with different modulating agents. Immunology (1992) 0.77
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci U S A (1980) 6.65
Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology (1986) 3.98
Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest (1983) 3.41
Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab (1983) 3.27
1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science (1984) 2.48
Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A (1983) 2.38
Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood (1983) 2.01
1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci U S A (1987) 1.89
Human pro-IL-1 beta gene expression in monocytic cells is regulated by two distinct pathways. J Immunol (1988) 1.61
Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol (1986) 1.53
1 alpha,25-dihydroxyvitamin D3 induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor. J Clin Invest (1984) 1.52
Expression and rescuing of a cloned human tumour necrosis factor gene using an EBV-based shuttle cosmid vector. EMBO J (1987) 1.48
1,25-Dihydroxyvitamin D3 activates secretion of hydrogen peroxide by human monocytes. J Immunol (1986) 1.09
Molecular biology of interleukin-1. Cold Spring Harb Symp Quant Biol (1986) 1.07
Differentiation of a human monocytic cell line by 1,25-dihydroxyvitamin D3 (calcitriol): a morphologic, phenotypic, and functional analysis. Blood (1984) 1.01
Interferon gamma drastically modifies the regulation of interleukin 1 genes by endotoxin in U937 cells. J Clin Invest (1990) 1.00
1,25-Dihydroxyvitamin D3, but not retinoic acid, induces the differentiation of U937 cells. Clin Exp Immunol (1989) 0.96
1,25-Dihydroxyvitamin D3 modulates the expression of a lymphokine (granulocyte-macrophage colony-stimulating factor) posttranscriptionally. J Clin Invest (1988) 0.94
1,25-Dihydroxyvitamin D3 transcriptionally regulates tumour necrosis factor mRNA during HL-60 cell differentiation. Immunology (1988) 0.81
Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG. J Exp Med (1977) 9.57
Cancer linked to Alzheimer disease but not vascular dementia. Neurology (2009) 4.83
Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation (1995) 2.62
Morphological and histochemical analyses of two human T-cell subpopulations bearing receptors for IgM or IgG. J Exp Med (1978) 2.58
Fc-receptor heterogeneity of human suppressor T cells. J Immunol (1978) 2.37
Raised serum IgG and IgA antibodies to mycobacterial antigens in rheumatoid arthritis. Ann Rheum Dis (1989) 1.85
Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease. Neurology (2011) 1.84
Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation (1999) 1.82
Imbalances in T cell subpopulations associated with immunodeficiency and autoimmune syndromes. Eur J Immunol (1977) 1.74
THE MEASUREMENT OF THE IODINE-ACCUMULATING FUNCTION OF THE HUMAN THYROID GLAND. J Clin Invest (1949) 1.72
A new scale for in-home test-weighing for mothers of preterm and high risk infants. J Hum Lact (1994) 1.69
Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol (1999) 1.68
RELATIVE MEASUREMENT IN VIVO OF ACCUMULATION OF RADIOIODINE BY THE HUMAN THYROID GLAND: COMPARISON WITH RADIOACTIVITY IN PERIPHERAL TISSUES. J Clin Invest (1949) 1.65
Ontogeny of B cells in the chicken. I. Sequential development of clonal diversity in the bursa. J Exp Med (1976) 1.63
Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clin Vaccine Immunol (2013) 1.51
Suppression of B lymphocyte differentiation by newborn T lymphocytes with an Fc receptor for IgM. Clin Exp Immunol (1978) 1.36
Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes. Biochem Pharmacol (1983) 1.36
Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis. Arthritis Rheum (2000) 1.34
Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures. J Exp Med (1981) 1.31
Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis. Arterioscler Thromb (1991) 1.30
Studies of generation of B-cell diversity in mouse, man, and chicken. Cold Spring Harb Symp Quant Biol (1977) 1.30
Idiotypic networks and their possible exploitation for manipulation of the immune response. Lancet (1981) 1.29
Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE. Immunology (1980) 1.22
Reduced B-cell galactosyltransferase activity in rheumatoid arthritis. Lancet (1987) 1.21
Autoimmunity and idiotypes. Lancet (1984) 1.17
Alzheimer disease identification using amyloid imaging and reserve variables: proof of concept. Neurology (2010) 1.15
CD5 expression in human B-cell populations. Immunol Today (1999) 1.15
Improvement in 'stat' laboratory turnaround time. A model continuous quality improvement project. Arch Intern Med (1992) 1.14
A minority of patients with rheumatoid arthritis show a dominant rearrangement of T-cell receptor beta chain genes in synovial lymphocytes. Scand J Immunol (1987) 1.13
Histamine suppression of lymphocyte activation. Clin Exp Immunol (1980) 1.12
Does hCG or hCGβ play a role in cancer cell biology? Mol Cell Endocrinol (2010) 1.11
The prevalence and distribution of macrophages bearing Fc gamma R I, Fc gamma R II, and Fc gamma R III in synovium. Scand J Rheumatol (1990) 1.11
MR imaging in pelvic inflammatory disease: comparison with laparoscopy and US. Radiology (1999) 1.10
Characteristics and function of Fc receptors on human lymphocytes. Immunology (1982) 1.09
Pathogenic autoantibodies in the NZB mouse are specific for erythrocyte band 3 protein. Eur J Immunol (1993) 1.08
Surface expression of heat shock protein 90 by blood mononuclear cells from patients with systemic lupus erythematosus. J Autoimmun (1992) 1.08
Chemotactic factor-induced membrane potential changes in rabbit neutrophils monitored by the fluorescent dye 3,3'-dipropylthiadicarbocyanine iodide. Biochim Biophys Acta (1980) 1.07
Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: production of IL-4. Lupus (2002) 1.06
Idiotypic determinants on human thyroglobulin autoantibodies derived from the serum of Hashimoto patients and EB virus transformed cell lines. Clin Exp Immunol (1984) 1.05
Detection of pseudomyxoma peritonei by radioimmunohistochemistry and radioimmunoscintigraphy. Cancer Biother Radiopharm (1996) 1.05
Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers. Lupus (2002) 1.05
Muscle power predicts freestyle swimming performance. Br J Sports Med (1992) 1.04
Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma. Int J Cancer (1997) 1.04
CD5-expressing B lymphocytes in the blood and salivary glands of patients with primary Sjögren's syndrome. J Autoimmun (1988) 1.03
Specificity of plasma cells in the rheumatoid synovium. I. Immunoglobulin class of antiglobulin-producing cells. Scand J Immunol (1984) 1.03
Recent progress in the understanding of B-cell functions in autoimmunity. Scand J Immunol (2001) 1.01
CD8+ T cells in human uterine endometrial lymphoid aggregates: evidence for accumulation of cells by trafficking. Immunology (2001) 1.01
Relationship between upper body anaerobic power and freestyle swimming performance. Int J Sports Med (1991) 1.01
Effect of cyclosporin A on T-dependent and T-independent immunoglobulin synthesis in vitro. Nature (1980) 0.99
Idiotypes and autoimmunity. Springer Semin Immunopathol (1983) 0.98
Auto- and polyreactivity of IgM from CD5+ and CD5- cord blood B cells. Scand J Immunol (1991) 0.97
Receptors for IgM are expressed on acute lymphoblastic leukemic cells having T-cell characteristics. Clin Immunol Immunopathol (1977) 0.97
Endothelial L-selectin ligands are likely to recruit lymphocytes into rejecting human heart transplants. Am J Pathol (1999) 0.97
MR imaging of overuse injuries of the Achilles tendon. AJR Am J Roentgenol (2000) 0.96
Ontogeny of B cells in the chicken. II. Changing patterns of cytoplasmic IgM expression and of modulation requirements for surface IgM by anti-mu antibodies. J Immunol (1977) 0.96
A common epitope identified by a monoclonal antibody, MID 2, present on all leucocytes and associated with a group of high molecular weight glycopeptides. Scand J Immunol (1984) 0.96
Alpha E beta 7 and alpha 4 beta 7 integrins associated with intraepithelial and mucosal homing, are expressed on macrophages. Eur J Immunol (1995) 0.96
1,25-Dihydroxyvitamin D3, but not retinoic acid, induces the differentiation of U937 cells. Clin Exp Immunol (1989) 0.96
Induction of suppression through human T cell interactions. Clin Exp Immunol (1980) 0.95
Modulation of human natural killer cell activity by pharmacological mediators. Clin Exp Immunol (1983) 0.94
Delineation of chicken lymphocyte populations by specific anti-thymus and anti-bursa sera. Cell Immunol (1972) 0.93
Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL). Clin Exp Immunol (2001) 0.93
Human lymphocyte antigens: a mini review. Biochem Soc Trans (1985) 0.93
Antibody mediated regulation of immune responses. I. Enhancement of specific antibody responses through IgM antibodies. Immunol Lett (1982) 0.93
Abnormal responses of rheumatoid arthritis lymphocytes to Epstein-Barr virus infection in vitro: evidence for multiple defects. Ann Rheum Dis (1985) 0.93
Bursal origin of bone marrow cells with competence for antibody formation. Immunology (1972) 0.93
Evidence for antibody-dependent cell-mediated cytotoxicity by T cells bearing receptors for IgG. Clin Exp Immunol (1979) 0.93
MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation. Invest Radiol (1999) 0.92
The effect of interleukin-10 and of interleukin-12 on the in vitro production of anti-double-stranded DNA antibodies from patients with systemic lupus erythematosus. Clin Exp Immunol (2001) 0.92
Production of erythrocyte autoantibodies in NZB mice is inhibited by CD4 antibodies. Clin Exp Immunol (1994) 0.92
II. IgM-mediated enhancement: dependency on antigen dose, T-cell requirement and lack of evidence for an idiotype-related mechanism. Immunology (1983) 0.91
Cytotoxicity of tumor necrosis factor for thyroid epithelial cells and its regulation by interferon-gamma. Eur J Immunol (1987) 0.91
Repair of chemical carcinogen-induced damage in DNA of human lymphocytes and lymphoid cell lines--studies of the kinetics of removal of O6-methylguanine and 3-methyladenine. Chem Biol Interact (1986) 0.91
Selective expression of a VHIV subfamily of immunoglobulin genes in human CD5+ B lymphocytes from cord blood. J Exp Med (1991) 0.91
Receptors for IgM on human lymphocytes. II. Mitogen-induced modulation of receptor expression. Clin Exp Immunol (1979) 0.91
The development of monoclonal antibodies to the human mitochondrial 60-kd heat-shock protein, and their use in studying the expression of the protein in rheumatoid arthritis. Arthritis Rheum (1992) 0.91
Evidence for B cell activation in patients with active rheumatoid arthritis. Clin Exp Immunol (1984) 0.91
Effect of cyclosporin A on in vitro proliferative activity and immunoglobulin synthesis of isolated human lymphoid cell subpopulations. Clin Exp Immunol (1981) 0.91
DNA vaccination favours memory rather than effector B cell responses. Clin Exp Immunol (1999) 0.91
Rheumatoid arthritis: how well do the theories fit the evidence? Clin Exp Immunol (1993) 0.91
Prostaglandin E2-mediated enhancement of human plasma cell differentiation. Immunol Lett (1982) 0.90
Interferon-mediated enhancement of thyroid major histocompatibility complex antigen expression. A flow cytometric analysis. Scand J Immunol (1987) 0.90
Polymorphism and expression of the galactosyltransferase-associated protein kinase gene in normal individuals and galactosylation-defective rheumatoid arthritis patients. Arthritis Rheum (1990) 0.89
Diverse antigen specificity of erythrocyte-reactive monoclonal autoantibodies from NZB mice. Clin Exp Immunol (1996) 0.89
Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells. Clin Exp Immunol (2002) 0.89
T gamma delta-cell subsets in cord and adult blood. Scand J Immunol (1990) 0.89
Role of B-cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells. Leukemia (2005) 0.89
Ezrin expression in tissue microarray of primary and recurrent gliomas. Neuropathol Appl Neurobiol (2004) 0.89
Early regulation of c-myc mRNA by 1,25-dihydroxyvitamin D3 in human myelomonocytic U937 cells. J Mol Endocrinol (1989) 0.89
IgG glycosylation in autoimmune-prone strains of mice. Clin Exp Immunol (1994) 0.89
Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo. Br J Haematol (1994) 0.88
The role of TG lymphocytes in cell-mediated immunity in patients with periodontal disease. Clin Exp Immunol (1981) 0.88
Chronic rejection of rat renal allografts. II. The impact of prolonged ischemia time on transplant histology. Transplantation (1992) 0.88
Sialyl Lewis(x)- and L-selectin-dependent site-specific lymphocyte extravasation into renal transplants during acute rejection. Eur J Immunol (1994) 0.88